Immune Checkpoint Inhibitor-Related Pneumonia in Unresectable Hepatocellular Carcinoma: Two Fatal Cases under Atezolizumab plus Bevacizumab

• Kei Endo,
• Hidekatsu Kuroda,
• Takayoshi Oikawa,
• Yuma Ito,
• Tamami Abe,
• Youhei Kooka,
• Keisuke Kakisaka,
• Akio Miyasaka,
• Tamotsu Sugai,
• Takayuki Matsumoto

Affiliations

Kei Endo

ORCiD

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan

Hidekatsu Kuroda

ORCiD

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan

Takayoshi Oikawa

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan

Yuma Ito

Department of Molecular Diagnostic Pathology, Iwate Medical University School of Medicine, Yahaba, Japan

Tamami Abe

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan

Youhei Kooka

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan

Keisuke Kakisaka

ORCiD

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan

Akio Miyasaka

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan

Tamotsu Sugai

Department of Molecular Diagnostic Pathology, Iwate Medical University School of Medicine, Yahaba, Japan

Takayuki Matsumoto

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan